500 patients66,097 observations150 daysLIVE
eligible for ME-01 · confidence ≥ 70%

Patients needing attention

Synthetic demo data
Clear
19
patients · eligible for ME-01 · confidence ≥ 70%
Most common reason
GI intolerance
Most effective previous action
GI-04
Nutritional protocol
Estimated addressable population
9
eligible for GI-04, confidence ≥ 70%
Predicted persistence gain
+17%
LLIFE OS insight · why this cohort goes where it goes
grounded · add an LLM key for prose

eligible for ME-01 · confidence ≥ 70%: 19 patients, mean day 134. 42% have deteriorating tolerance, 79% unstable GI, 100% carry ≥60% discontinuation risk; mean GI 66, adherence 58%. Dominant clusters: EC-03 53%, LT 47%.

Shared biology: Low microbial diversity 79%, Low butyrate capacity 68%, FUT2 non-secretor 63%, IL6 high-expression variant 58%, Cluster EC-03 (high response / high intolerance) 53%, Adherence < 60% 53%, Baseline state S14 47%. Dietary detractors: fat in 89%, histamine in 63%, lactose in 63%.

What worked: GI-04 improved 75% of 4; what did not: NP-02 improved only 50% of 4.

No learned rules apply yet; run learning after the first campaign results.

PatientDayBaselineGIToleranceGI scoreDiscontinuationCluster
P-03067150S14UnstableDeteriorating7296%EC-03
P-03177140S10UnstableStable8196%LT
P-03375139S14UnstableDeteriorating7196%EC-03
P-03345140S14UnstableStable6995%EC-03
P-03230149S09UnstableImproving7394%EC-03
P-03058140S14UnstableStable6793%EC-03
P-03301109S12UnstableFavorable7091%LT
P-03459145S14ImprovingImproving5688%EC-03
P-03034138S14UnstableStable7885%EC-03
P-03405116S14ImprovingImproving5884%EC-03
P-03500139S14StableImproving5281%EC-03
P-03153143S08UnstableDeteriorating6780%LT
P-03473116S01UnstableDeteriorating6179%LT
P-03475120S14UnstableDeteriorating6878%LT
P-03109143S03DeterioratingDeteriorating5876%EC-03
P-03253147S15UnstableStable6975%LT
P-03303128S16UnstableStable6171%LT
P-03273119S15UnstableDeteriorating5868%LT
P-03227121S05UnstableDeteriorating6262%LT